BD to Present at Wells Fargo 2024 Healthcare Conference
BD (Becton, Dickinson and Company), a leading global medical technology company, has announced its participation in the Wells Fargo 2024 Healthcare Conference. The presentation is scheduled for Wednesday, September 4, 2024, at 8:45 am Eastern Time.
Investors and interested parties can access the live webcast of BD's presentation through the company's investor relations website at investors.bd.com. For those unable to attend the live event, a replay will be made available on the same webpage after the presentation concludes.
This conference provides BD with an opportunity to showcase its latest developments and strategies to investors and industry professionals. The company's participation underscores its commitment to transparency and engagement with the financial community.
BD (Becton, Dickinson and Company), un primario leader globale nel settore della tecnologia medica, ha annunciato la sua partecipazione al Wells Fargo 2024 Healthcare Conference. La presentazione è programmata per mercoledì 4 settembre 2024, alle 8:45 ora orientale.
Investitori e parti interessate possono accedere al webinar dal vivo della presentazione di BD attraverso il sito web delle relazioni con gli investitori della società su investors.bd.com. Per coloro che non possono partecipare all'evento dal vivo, sarà disponibile un replay sulla stessa pagina dopo la conclusione della presentazione.
Questa conferenza offre a BD l'opportunità di presentare i suoi ultimi sviluppi e strategie agli investitori e ai professionisti del settore. La partecipazione dell'azienda sottolinea il suo impegno per la trasparenza e l'impegno con la comunità finanziaria.
BD (Becton, Dickinson and Company), una empresa líder global en tecnología médica, ha anunciado su participación en la Conferencia de Salud de Wells Fargo 2024. La presentación está programada para el miércoles 4 de septiembre de 2024, a las 8:45 horas del Este.
Los inversores y partes interesadas pueden acceder a la transmisión en vivo de la presentación de BD a través del sitio web de relaciones con inversores de la compañía en investors.bd.com. Para aquellos que no puedan asistir al evento en vivo, se hará disponible una repetición en la misma página después de que concluyan la presentación.
Esta conferencia ofrece a BD una oportunidad para mostrar sus últimos desarrollos y estrategias a inversores y profesionales del sector. La participación de la empresa subraya su compromiso con la transparencia y la interacción con la comunidad financiera.
BD(Becton, Dickinson and Company)는 세계적인 의료기술 회사의 선두주자로서 웰스파고 2024 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 발표는 2024년 9월 4일 수요일, 동부 표준시 기준으로 오전 8시 45분에 예정되어 있습니다.
투자자 및 이해관계자는 BD의 발표를 실시간으로 접속할 수 있으며, 이 회사의 투자자 관계 웹사이트 investors.bd.com를 통해 가능합니다. 실시간 이벤트에 참석할 수 없는 경우, 발표가 종료된 후 동일한 웹페이지에서 재생이 제공됩니다.
이번 컨퍼런스는 BD가 투자자 및 산업 전문가들에게 최신 개발 사항 및 전략을 선보일 수 있는 기회를 제공합니다. 회사의 참여는 재무 커뮤니티와의 투명성과 소통을 위한 헌신을 강조합니다.
BD (Becton, Dickinson and Company), une entreprise leader mondiale en technologie médicale, a annoncé sa participation à la Conférence de Santé Wells Fargo 2024. La présentation est prévue pour mercredi 4 septembre 2024, à 8h45, heure de l'Est.
Les investisseurs et les parties intéressées peuvent accéder à la diffusion en direct de la présentation de BD via le site web des relations investisseurs de la société à investors.bd.com. Pour ceux qui ne peuvent pas assister à l'événement en direct, une rediffusion sera disponible sur la même page après la fin de la présentation.
Cette conférence offre à BD l'occasion de présenter ses derniers développements et stratégies aux investisseurs et aux professionnels du secteur. La participation de l'entreprise souligne son engagement envers la transparence et l'interaction avec la communauté financière.
BD (Becton, Dickinson and Company), ein führendes globales Medizintechnikunternehmen, hat seine Teilnahme an der Wells Fargo 2024 Healthcare Conference angekündigt. Die Präsentation ist für Mittwoch, den 4. September 2024, um 8:45 Uhr nach Eastern Time geplant.
Investoren und Interessierte können über die Website der Investor Relations von BD auf die Live-Übertragung der Präsentation zugreifen unter investors.bd.com. Für diejenigen, die an der Live-Veranstaltung nicht teilnehmen können, wird auf derselben Webseite nach Abschluss der Präsentation ein Wiederholungsangebot bereitgestellt.
Diese Konferenz bietet BD eine Gelegenheit, seine neuesten Entwicklungen und Strategien Investoren und Fachleuten der Branche vorzustellen. Die Teilnahme des Unternehmens unterstreicht sein Engagement für Transparenz und den Dialog mit der Finanzgemeinschaft.
- None.
- None.
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
Contacts: | |
Media: | Investors: |
Troy Kirkpatrick | Adam Reiffe |
VP, Public Relations | Sr. Director, Investor Relations |
858.617.2361 | 201.847.6927 |
View original content:https://www.prnewswire.com/news-releases/bd-to-present-at-wells-fargo-2024-healthcare-conference-302218247.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
When is BD (BDX) presenting at the Wells Fargo 2024 Healthcare Conference?
How can I watch BD's (BDX) presentation at the Wells Fargo 2024 Healthcare Conference?
Will there be a replay available of BD's (BDX) presentation at the Wells Fargo conference?
What is the stock symbol for BD mentioned in the press release?
